PROTRITAC
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Nov 2025)
What this means for you
This application is over — abandoned 10 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97559351
- Mark type
- Stylized text
- Filed
- 22 Aug 2022
- Published for opposition
- 15 Aug 2023
- Abandoned
- 10 Nov 2025
- Attorney of record
- Lisa M. Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 10 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2025 — SOU EXTENSION 3 GRANTED
- 02 Apr 2025 — SOU EXTENSION 3 FILED
- 02 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 2 GRANTED
- 12 Sept 2024 — SOU EXTENSION 2 FILED
- 12 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2024 — SOU EXTENSION 1 GRANTED
- 02 Apr 2024 — SOU EXTENSION 1 FILED
- 02 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED